Literature DB >> 24499438

Recent patents and patented technology platforms for pharmaceutical taste masking.

Deepak Kaushik, Harish Dureja1.   

Abstract

Taste masking is an important factor in the development of oral dosage forms containing bitter active pharmaceutical ingredients. Currently numerous techniques are being applied to overcome this problem. Realizing this, several researchers and pharmaceutical companies are now engaged in developing novel techniques to address the problem of taste masking evident by numerous patents filed in this area in recent times. In this review the most recent patents for taste masking are discussed and how these patents overcome the limitations of conventional approaches of taste masking is also highlighted. Novel techniques based on some recent patents such as nanohybrid, melt extrusion, non-complex cyclodextrin compositions and off taste masking are providing new realms to taste masking of bitter drugs. The present article also provides an overview of various patented platform technologies based on different techniques/mechanisms employed for taste masking. The unique features and principles of taste-masking approaches used in various patented technologies are also discussed. A better understanding of these new patents and patented technologies will help researchers and pharmaceutical industries to select the appropriate platform, or to develop innovative products with improved taste masking properties.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24499438     DOI: 10.2174/1872211308666140206150840

Source DB:  PubMed          Journal:  Recent Pat Drug Deliv Formul        ISSN: 1872-2113


  2 in total

1.  Study on Masking the Bitterness of Chinese Medicine Decoction-Mate.

Authors:  Fuguo Hou; Yan Miao; Xiangxiang Wu; Xinjing Gui; Yanli Wang; Haiyang Li; Junhan Shi; Lu Zhang; Jing Yao; Xuelin Li; Ruixin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-09       Impact factor: 2.650

2.  Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles.

Authors:  Aleksandra Amelian; Katarzyna Wasilewska; Małgorzata Wesoły; Patrycja Ciosek-Skibińska; Katarzyna Winnicka
Journal:  Saudi Pharm J       Date:  2017-06-19       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.